The infectious disease diagnostic market was valued at $23.321 billion in 2020 and is projected to reach $39.941 billion by 2030, growing at a CAGR of 6.8%.
Becton Dickinson's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.